{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:41:33Z","timestamp":1788964893619,"version":"build-2803163510"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005274","name":"North-West University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005274","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The pathogenesis of tuberculous meningitis (TBM) involves infection by<jats:italic>Mycobacterium tuberculosis<\/jats:italic>in the meninges and brain. However, recent studies have shown that the immune response and inflammatory processes triggered by TBM can have significant effects on gut microbiota. Disruptions in the gut microbiome have been linked to various systemic consequences, including altered immunity and metabolic dysregulation. Inflammation caused by TBM, antibiotic treatment, and changes in host immunity can all influence the composition of gut microbes. This complex relationship between TBM and the gut microbiome is of great importance in clinical settings. To gain a deeper understanding of the intricate interactions between TBM and the gut microbiome, we report innovative insights into the development of the disease in response to treatment. Ultimately, this could lead to improved outcomes, management strategies and quality of life for individuals affected by TBM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>We used a targeted liquid chromatography\u2013tandem mass spectrometry (LC-MS\/MS) approach to investigate metabolites associated with gut metabolism in paediatric participants by analysing the urine samples collected from a control group (<jats:italic>n<\/jats:italic>\u2009=\u200940), and an experimental group (<jats:italic>n<\/jats:italic>\u2009=\u200935) with confirmed TBM, which were subdivided into TBM stage 1 (<jats:italic>n<\/jats:italic>\u2009=\u20098), stage 2 (<jats:italic>n<\/jats:italic>\u2009=\u200911) and stage 3 (<jats:italic>n<\/jats:italic>\u2009=\u200916).<\/jats:p><\/jats:sec><jats:sec><jats:title>Findings<\/jats:title><jats:p>Our metabolomics investigation showed that, of the 78 initially selected compounds of microbiome origin, eight unique urinary metabolites were identified: 2-methylbutyrlglycine, 3-hydroxypropionic acid, 3-methylcrotonylglycine, 4-hydroxyhippuric acid, 5-hydroxyindoleacetic acid, 5-hydroxyhexanoic acid, isobutyrylglycine, and phenylacetylglutamine as urinary markers of dysbiosis in TBM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These results \u2013 which are supported by previous urinary studies of tuberculosis \u2013 highlight the importance of gut metabolism and of identifying corresponding microbial metabolites as novel points for the foundation of improved management of TBM patients.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13099-024-00609-9","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T20:04:04Z","timestamp":1710273844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Urinary markers of Mycobacterium tuberculosis and dysbiosis in paediatric tuberculous meningitis cases undergoing treatment"],"prefix":"10.1186","volume":"16","author":[{"given":"Simon","family":"Isaiah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du Toit","family":"Loots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Marceline Tutu","family":"van Furth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmarie","family":"Davoren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"van Elsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regan","family":"Solomons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"van der Kuip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayne","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"issue":"1","key":"609_CR1","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","volume":"4","author":"S Bagcchi","year":"2023","unstructured":"Bagcchi S. WHO\u2019s global tuberculosis report 2022. Lancet Microbe. 2023;4(1):e20.","journal-title":"Lancet Microbe"},{"key":"609_CR2","doi-asserted-by":"publisher","first-page":"1099654","DOI":"10.3389\/fmolb.2023.1099654","volume":"10","author":"Y Yu","year":"2023","unstructured":"Yu Y, et al. Biomarker discovery for tuberculosis using metabolomics. Front Mol Biosci. 2023;10:1099654.","journal-title":"Front Mol Biosci"},{"key":"609_CR3","doi-asserted-by":"publisher","first-page":"751133","DOI":"10.3389\/fneur.2022.751133","volume":"13","author":"K du Preez","year":"2022","unstructured":"du Preez K, et al. Tuberculous meningitis in children: a forgotten public health emergency. Front Neurol. 2022;13:751133.","journal-title":"Front Neurol"},{"issue":"3","key":"609_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S1474-4422(05)70019-3","volume":"4","author":"GE Thwaites","year":"2005","unstructured":"Thwaites GE, Hien TT. Tuberculous meningitis: many questions, too few answers. Lancet Neurol. 2005;4(3):160\u201370.","journal-title":"Lancet Neurol"},{"issue":"11","key":"609_CR5","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3390\/vaccines9111228","volume":"9","author":"N Shaikh","year":"2021","unstructured":"Shaikh N, et al. Impact of COVID-19 disruptions on global BCG coverage and paediatric TB mortality: a modelling study. Vaccines. 2021;9(11):1228.","journal-title":"Vaccines"},{"key":"609_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.12688\/wellcomeopenres.15535.1","volume":"4","author":"JA Seddon","year":"2019","unstructured":"Seddon JA, et al. The current global situation for tuberculous meningitis: epidemiology, diagnostics, treatment and outcomes. Wellcome Open Res. 2019;4:167.","journal-title":"Wellcome Open Res"},{"issue":"1","key":"609_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/pathogens11010038","volume":"11","author":"J Huynh","year":"2022","unstructured":"Huynh J, et al. Tuberculous meningitis in children: reducing the Burden of Death and Disability. J Pathog. 2022;11(1):38.","journal-title":"J Pathog"},{"key":"609_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11306-016-1053-2","volume":"12","author":"S Mason","year":"2016","unstructured":"Mason S, et al. A putative urinary biosignature for diagnosis and follow-up of tuberculous meningitis in children: outcome of a metabolomics study disclosing host\u2013pathogen responses. Metabolomics. 2016;12:1\u201316.","journal-title":"Metabolomics"},{"issue":"5","key":"609_CR9","doi-asserted-by":"publisher","first-page":"e0124194","DOI":"10.1371\/journal.pone.0124194","volume":"10","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, et al. Correlation between either Cupriavidus or Porphyromonas and primary pulmonary tuberculosis found by analysing the microbiota in patients\u2019 bronchoalveolar lavage fluid. PLoS ONE. 2015;10(5):e0124194.","journal-title":"PLoS ONE"},{"issue":"7","key":"609_CR10","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s10096-016-2654-4","volume":"35","author":"P Krishna","year":"2016","unstructured":"Krishna P, et al. Microbiome diversity in the sputum of patients with pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis. 2016;35(7):1205\u201310.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"609_CR11","doi-asserted-by":"crossref","unstructured":"Isaiah S et al. Urinary metabolic characterization of advanced tuberculous meningitis cases in a South African paediatric population. (under review) 2023.","DOI":"10.3389\/fmolb.2024.1253983"},{"issue":"10","key":"609_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s11306-017-1261-4","volume":"13","author":"L Luies","year":"2017","unstructured":"Luies L, et al. Urinary metabolite markers characterizing tuberculosis treatment failure. Metabolomics. 2017;13(10):124.","journal-title":"Metabolomics"},{"issue":"2","key":"609_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/metabo12020194","volume":"12","author":"V Gonzalez-Covarrubias","year":"2022","unstructured":"Gonzalez-Covarrubias V, et al. The potential of Metabolomics in Biomedical Applications. Metabolites. 2022;12(2):194.","journal-title":"Metabolites"},{"issue":"5","key":"609_CR14","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1021\/pr101054m","volume":"10","author":"JH Shin","year":"2011","unstructured":"Shin JH, et al. 1H NMR-based Metabolomic Profiling in mice infected with Mycobacterium tuberculosis. J Proteome Res. 2011;10(5):2238\u201347.","journal-title":"J Proteome Res"},{"issue":"2","key":"609_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.mimet.2012.09.002","volume":"91","author":"JC Schoeman","year":"2012","unstructured":"Schoeman JC, Du Preez I. A comparison of four sputum pre-extraction preparation methods for identifying and characterising Mycobacterium tuberculosis using GCxGC-TOFMS metabolomics. J Microbiol Methods. 2012;91(2):301\u201311.","journal-title":"J Microbiol Methods"},{"issue":"3","key":"609_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.tube.2013.02.008","volume":"93","author":"I Du Preez","year":"2013","unstructured":"Du Preez I, Loots D. New Sputum metabolite markers implicating adaptations of the host to Mycobacterium tuberculosis, and vice versa. J Tuberc. 2013;93(3):330\u20137.","journal-title":"J Tuberc"},{"issue":"7","key":"609_CR17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/INF.0000000000003922","volume":"42","author":"C Mckenzie","year":"2023","unstructured":"Mckenzie C, et al. Recurrent tuberculosis treatment episodes in children presenting with Presumptive Pulmonary Tuberculosis in Cape Town, South Africa. J Pediatr Infect Dis. 2023;42(7):543\u20138.","journal-title":"J Pediatr Infect Dis"},{"key":"609_CR18","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/j.ijid.2021.02.003","volume":"113","author":"BJ Marais","year":"2021","unstructured":"Marais BJ, et al. Paediatric tuberculosis \u2013 new advances to close persistent gaps. Int J Infect Dis. 2021;113:S63\u20137.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"609_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12890-023-02329-3","volume":"23","author":"I Dewandel","year":"2023","unstructured":"Dewandel I, et al. UMOYA: a prospective longitudinal cohort study to evaluate novel diagnostic tools and to assess long-term impact on lung health in South African children with presumptive pulmonary TB\u2014a study protocol. BMC Pulm Med. 2023;23(1):97.","journal-title":"BMC Pulm Med"},{"issue":"3","key":"609_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/INF.0000000000000065","volume":"33","author":"R van Toorn","year":"2014","unstructured":"van Toorn R, et al. Short intensified treatment in children with drug-susceptible tuberculous meningitis. J Pediatr Infect Dis. 2014;33(3):248\u201352.","journal-title":"J Pediatr Infect Dis"},{"issue":"5","key":"609_CR21","doi-asserted-by":"publisher","first-page":"628","DOI":"10.5588\/ijtld.11.0648","volume":"16","author":"R Van Toorn","year":"2012","unstructured":"Van Toorn R, et al. Value of different staging systems for predicting neurological outcome in childhood tuberculous meningitis. Int J Tuberc Lung Dis. 2012;16(5):628\u201332.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"609_CR22","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S1473-3099(10)70138-9","volume":"10","author":"S Marais","year":"2010","unstructured":"Marais S, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis. 2010;10(11):803\u201312.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"609_CR23","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/tmi.13134","volume":"23","author":"SL van Elsland","year":"2018","unstructured":"van Elsland SL, et al. A treatment-support intervention evaluated in South African paediatric populations with HIV infection or tuberculous meningitis. Trop Med Int Health. 2018;23(10):1129\u201340.","journal-title":"Trop Med Int Health"},{"key":"609_CR24","doi-asserted-by":"crossref","unstructured":"Jiang J et al. Metabolomics strategy assisted by transcriptomics analysis to identify potential biomarkers associated with tuberculosis. Infect Drug Resist, 2021: p. 4795\u2013807.","DOI":"10.2147\/IDR.S330493"},{"key":"609_CR25","doi-asserted-by":"publisher","first-page":"988290","DOI":"10.3389\/fonc.2022.988290","volume":"12","author":"X Nong","year":"2022","unstructured":"Nong X, et al. The mechanism of branched-chain amino acid transferases in different diseases: Research progress and future prospects. Front Oncol. 2022;12:988290.","journal-title":"Front Oncol"},{"issue":"3","key":"609_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11306-016-0969-x","volume":"12","author":"L Luier","year":"2016","unstructured":"Luier L, Loots DT. Tuberculosis metabolomics reveals adaptations of man and microbe in order to outcompete and survive. Metabolomics. 2016;12(3):40.","journal-title":"Metabolomics"},{"key":"609_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fbioe.2019.00124","volume":"7","author":"C Jers","year":"2019","unstructured":"Jers C, et al. Production of 3-hydroxypropanoic acid from glycerol by metabolically engineered bacteria. Front Bioeng Biotechnol. 2019;7:124.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1\u20132","key":"609_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0009-8981(78)90030-X","volume":"82","author":"M Duran","year":"1978","unstructured":"Duran M, et al. The variability of metabolite excretion in propionicacidaemia. Clin Chim Acta. 1978;82(1\u20132):93\u20139.","journal-title":"Clin Chim Acta"},{"issue":"2\u20133","key":"609_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0009-8981(87)90314-7","volume":"169","author":"R Pollitt","year":"1987","unstructured":"Pollitt R, et al. Increased excretion of propan-1, 3-diol and 3-hydroxypropionic acid apparently caused by abnormal bacterial metabolism in the gut. Clin Chim Acta. 1987;169(2\u20133):151\u20137.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"609_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF01801669","volume":"8","author":"R Pollitt","year":"1985","unstructured":"Pollitt R, et al. Excessive excretion of \u03b2-alanine and of 3-hydroxypropionic, R-and S-3-aminoisobutyric, R-and S-3-hydroxyisobutyric and S-2-(hydroxymethyl) butyric acids probably due to a defect in the metabolism of the corresponding malonic semialdehydes. J Inherit Metab Dis. 1985;8(2):75\u20139.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"609_CR31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF01799979","volume":"10","author":"G Brown","year":"1987","unstructured":"Brown G, et al. Urinary organic acids in succinic semialdehyde dehydrogenase deficiency: evidence of \u03b1-oxidation of 4\u2010hydroxybutyric acid, interaction of succinic semialdehyde with pyruvate dehydrogenase and possible secondary inhibition of mitochondrial \u03b2\u2010oxidation. J Inherit Metab Dis. 1987;10(4):367\u201375.","journal-title":"J Inherit Metab Dis"},{"key":"609_CR32","unstructured":"http:\/\/www.hmdb.ca\/metabolites\/HMDB0000700, -. Available from: - http:\/\/www.hmdb.ca\/metabolites\/HMDB0000700."},{"issue":"6","key":"609_CR33","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.biotechadv.2013.02.008","volume":"31","author":"V Kumar","year":"2013","unstructured":"Kumar V, et al. Recent advances in biological production of 3-hydroxypropionic acid. Biotechnol Adv. 2013;31(6):945\u201361.","journal-title":"Biotechnol Adv"},{"issue":"10","key":"609_CR34","doi-asserted-by":"publisher","first-page":"6788","DOI":"10.1074\/jbc.M112.445056","volume":"288","author":"W Lee","year":"2013","unstructured":"Lee W, et al. Intracellular Mycobacterium tuberculosis exploits host-derived fatty acids to limit metabolic stress. J Biol Chem. 2013;288(10):6788\u2013800.","journal-title":"J Biol Chem"},{"issue":"2","key":"609_CR35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1600-079X.2004.00176.x","volume":"38","author":"DT Loots","year":"2005","unstructured":"Loots DT, et al. Melatonin prevents the free radical and MADD metabolic profiles induced by antituberculosis drugs in an animal model. J Pineal Res. 2005;38(2):100\u20136.","journal-title":"J Pineal Res"},{"issue":"11","key":"609_CR36","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1016\/j.celrep.2019.11.037","volume":"29","author":"K Borah","year":"2019","unstructured":"Borah K, et al. Intracellular Mycobacterium tuberculosis exploits multiple host nitrogen sources during growth in human macrophages. Cell Rep. 2019;29(11):3580\u201391. e4.","journal-title":"Cell Rep"},{"issue":"11","key":"609_CR37","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrmicro3349","volume":"12","author":"A Gouzy","year":"2014","unstructured":"Gouzy A, et al. Nitrogen metabolism in Mycobacterium tuberculosis physiology and virulence. Nat Rev Microbiol. 2014;12(11):729\u201337.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"609_CR38","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/iub.2455","volume":"73","author":"SD Yelamanchi","year":"2021","unstructured":"Yelamanchi SD, Surolia A. Targeting amino acid metabolism of Mycobacterium tuberculosis for developing inhibitors to curtail its survival. IUBMB Life. 2021;73(4):643\u201358.","journal-title":"IUBMB Life"},{"issue":"2","key":"609_CR39","first-page":"129","volume":"124","author":"AV Kurpad","year":"2006","unstructured":"Kurpad AV. The requirements of protein & amino acid during acute & chronic infections. Indian J Med Sci. 2006;124(2):129\u201348.","journal-title":"Indian J Med Sci"},{"key":"609_CR40","doi-asserted-by":"crossref","unstructured":"Amalia F et al. The role of amino acids in tuberculosis infection: a Literature Review. Metabolites, 2022. 12(10).","DOI":"10.3390\/metabo12100933"},{"key":"609_CR41","unstructured":"Ardiansyah E et al. Tryptophan metabolism determines outcome in tuberculous meningitis: a targeted metabolomic analysis. Elife, 2023. 12."},{"issue":"5","key":"609_CR42","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S1473-3099(18)30053-7","volume":"18","author":"A van Laarhoven","year":"2018","unstructured":"van Laarhoven A, et al. Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study. Lancet Infect Dis. 2018;18(5):526\u201335.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"609_CR43","doi-asserted-by":"publisher","first-page":"IJE17","DOI":"10.2217\/ije-2019-0001","volume":"6","author":"M Ewang-Emukowhate","year":"2019","unstructured":"Ewang-Emukowhate M, et al. The role of 5-hydroxyindoleacetic acid in neuroendocrine tumors: the journey so far. Int J Endocr Oncol. 2019;6(2):IJE17.","journal-title":"Int J Endocr Oncol"},{"issue":"1","key":"609_CR44","doi-asserted-by":"publisher","first-page":"e4135","DOI":"10.1002\/bmc.4135","volume":"32","author":"A Szeitz","year":"2018","unstructured":"Szeitz A, Bandiera SM. Analysis and measurement of serotonin. Biomed Chromatogr. 2018;32(1):e4135.","journal-title":"Biomed Chromatogr"},{"issue":"5","key":"609_CR45","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1210\/en.2016-1839","volume":"158","author":"AM Martin","year":"2017","unstructured":"Martin AM, et al. The diverse metabolic roles of peripheral serotonin. J Endocrinol. 2017;158(5):1049\u201363.","journal-title":"J Endocrinol"},{"key":"609_CR46","doi-asserted-by":"crossref","unstructured":"Cen P, et al. Chap. 3 - biomarkers in Oncology and Nephrology. Renal disease in Cancer patients. Academic; 2014. pp. 21\u201338. K.W. Finkel and S.C. Howard, Editors.","DOI":"10.1016\/B978-0-12-415948-8.00003-9"},{"issue":"4","key":"609_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pediatrneurol.2015.04.016","volume":"53","author":"LH Rodan","year":"2015","unstructured":"Rodan LH, et al. Clinical use of CSF neurotransmitters. Pediatr Neurol. 2015;53(4):277\u201386.","journal-title":"Pediatr Neurol"},{"key":"609_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-016-0711-0","volume":"18","author":"CF Gasparini","year":"2017","unstructured":"Gasparini CF, et al. Genetic and biochemical changes of the serotonergic system in migraine pathobiology. J Headache Pain. 2017;18:1\u201324.","journal-title":"J Headache Pain"},{"issue":"3","key":"609_CR49","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000461583","volume":"105","author":"G Kaltsas","year":"2017","unstructured":"Kaltsas G, et al. ENETS Consensus guidelines for the standards of Care in Neuroendocrine tumors: pre- and perioperative therapy in patients with neuroendocrine tumors. J Neuroendocrinol. 2017;105(3):245\u201354.","journal-title":"J Neuroendocrinol"},{"key":"609_CR50","doi-asserted-by":"crossref","unstructured":"Cheetham S, et al. Post-mortem studies of neurotransmitter biochemistry in depression and suicide, in Biological aspects of affective disorders. Elsevier; 1991. pp. 191\u2013221.","DOI":"10.1016\/B978-0-12-356510-5.50012-1"},{"key":"609_CR51","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2014.07.027","volume":"277","author":"SM O\u2019Mahony","year":"2015","unstructured":"O\u2019Mahony SM, et al. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. 2015;277:32\u201348.","journal-title":"Behav Brain Res"},{"key":"609_CR52","doi-asserted-by":"crossref","unstructured":"Roth W et al. Tryptophan metabolism and Gut-Brain Homeostasis. Int J Mol Sci, 2021. 22(6).","DOI":"10.3390\/ijms22062973"},{"key":"609_CR53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coi.2020.12.001","volume":"70","author":"A Fiore","year":"2021","unstructured":"Fiore A, Murray PJ. Tryptophan and indole metabolism in immune regulation. Curr Opin Immunol. 2021;70:7\u201314.","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"609_CR54","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1248\/bpb.33.550","volume":"33","author":"SJ Bae","year":"2010","unstructured":"Bae SJ, et al. The anti-apoptotic action of 5-hydroxyindole: protection of mitochondrial integrity. Biol Pharm Bull. 2010;33(4):550\u20135.","journal-title":"Biol Pharm Bull"},{"issue":"9","key":"609_CR55","doi-asserted-by":"publisher","first-page":"834","DOI":"10.3390\/metabo12090834","volume":"12","author":"M Liu","year":"2022","unstructured":"Liu M, et al. Microbial tryptophan metabolism tunes host immunity, metabolism, and extraintestinal disorders. Metabolites. 2022;12(9):834.","journal-title":"Metabolites"},{"key":"609_CR56","doi-asserted-by":"crossref","unstructured":"Zhang Q et al. Gut microbiota-derived 5-hydroxyindoleacetic acid from Pumpkin Polysaccharides supplementation alleviates colitis through Epac\/Rap1 signaling activation 2023.","DOI":"10.21203\/rs.3.rs-3123790\/v1"},{"issue":"3","key":"609_CR57","doi-asserted-by":"publisher","first-page":"e01204","DOI":"10.1128\/msystems.01204-21","volume":"7","author":"F Li","year":"2022","unstructured":"Li F, et al. Multi-omic profiling reveals that intra-abdominal-hypertension-induced intestinal damage can be prevented by microbiome and metabolic modulations with 5-hydroxyindoleacetic acid as a diagnostic marker. Msystems. 2022;7(3):e01204\u201321.","journal-title":"Msystems"},{"key":"609_CR58","unstructured":"Lihui, Guo et al. Major IDO2 expression and activity related to autophagy and apoptosis in brain tissue of fatal TBM. (In)."},{"issue":"Suppl 1","key":"609_CR59","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1073\/pnas.1000098107","volume":"108","author":"J van Duynhoven","year":"2011","unstructured":"van Duynhoven J, et al. Metabolic fate of polyphenols in the human superorganism. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4531\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"609_CR60","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0009-8981(82)90254-6","volume":"125","author":"JP Kamerling","year":"1982","unstructured":"Kamerling JP, et al. The absolute configuration of urinary 5-hydroxyhexanoic acid \u2014 a product of fatty acid (\u03c9-1)-oxidation \u2014 in patients with non-ketotic dicarboxylic aciduria. Clin Chim Acta. 1982;125(3):247\u201354.","journal-title":"Clin Chim Acta"},{"issue":"10","key":"609_CR61","doi-asserted-by":"publisher","first-page":"p1661","DOI":"10.1093\/clinchem\/27.10.1661","volume":"27","author":"Y Shigematsu","year":"1981","unstructured":"Shigematsu Y, et al. (omega-1)-Hydroxymonocarboxylic acids in urine of infants fed medium-chain triglycerides. Clin Chem. 1981;27(10):p1661\u20131664.","journal-title":"Clin Chem"},{"issue":"1","key":"609_CR62","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/adc.88.1.88-a","volume":"88","author":"V Kairamkonda","year":"2003","unstructured":"Kairamkonda V, et al. Perforated duodenal ulcer disclosing medium chain acyl-CoA dehydrogenase deficiency. Arch Dis Child. 2003;88(1):88\u20139.","journal-title":"Arch Dis Child"},{"key":"609_CR63","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jchromb.2012.08.012","volume":"907","author":"J Niu","year":"2012","unstructured":"Niu J, et al. Effect of ginseng polysaccharide on the urinary excretion of type 2 diabetic rats studied by liquid chromatography\u2013mass spectrometry. J Chromatogr B. 2012;907:7\u201312.","journal-title":"J Chromatogr B"},{"issue":"11","key":"609_CR64","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1681\/ASN.2015121302","volume":"27","author":"R Poesen","year":"2016","unstructured":"Poesen R, et al. Microbiota-derived Phenylacetylglutamine Associates with overall mortality and Cardiovascular Disease in patients with CKD. J Am Soc Nephrol. 2016;27(11):3479\u201387.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"609_CR65","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","volume":"19","author":"KA Krautkramer","year":"2021","unstructured":"Krautkramer KA, et al. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2021;19(2):77\u201394.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"609_CR66","doi-asserted-by":"publisher","first-page":"19780","DOI":"10.1038\/srep19780","volume":"6","author":"J Mayneris-Perxachs","year":"2016","unstructured":"Mayneris-Perxachs J, et al. Urinary N-methylnicotinamide and \u03b2-aminoisobutyric acid predict catch-up growth in undernourished Brazilian children. Sci Rep. 2016;6(1):19780.","journal-title":"Sci Rep"},{"issue":"4","key":"609_CR67","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1021\/acs.jproteome.5b00016","volume":"14","author":"MK Das","year":"2015","unstructured":"Das MK, et al. Deregulated tyrosine\u2013phenylalanine metabolism in pulmonary tuberculosis patients. J Proteome Res. 2015;14(4):1947\u201356.","journal-title":"J Proteome Res"},{"issue":"6","key":"609_CR68","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1021\/pr901188e","volume":"9","author":"IK Yap","year":"2010","unstructured":"Yap IK, et al. Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res. 2010;9(6):2996\u20133004.","journal-title":"J Proteome Res"},{"issue":"5","key":"609_CR69","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.1365-2958.2006.05155.x","volume":"60","author":"EJ Mu\u00f1oz-El\u00edas","year":"2006","unstructured":"Mu\u00f1oz-El\u00edas EJ, et al. Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence. Mol Microbiol. 2006;60(5):1109\u201322.","journal-title":"Mol Microbiol"},{"issue":"11","key":"609_CR70","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1128\/JB.01767-07","volume":"190","author":"S Savvi","year":"2008","unstructured":"Savvi S, et al. Functional characterization of a vitamin B\u2009<\u2009sub\u2009>\u200912-Dependent methylmalonyl pathway in <\u2009i\u2009>\u2009Mycobacterium tuberculosis: implications for Propionate metabolism during growth on fatty acids. J Bacteriol. 2008;190(11):3886\u201395.","journal-title":"J Bacteriol"},{"key":"609_CR71","doi-asserted-by":"crossref","unstructured":"Chandra P et al. Macrophage global metabolomics identifies cholestenone as host\/pathogen cometabolite present in human Mycobacterium tuberculosis infection. J Clin Investig, 2022. 132(3).","DOI":"10.1172\/JCI152509"},{"issue":"2","key":"609_CR72","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.chembiol.2011.12.016","volume":"19","author":"JE Griffin","year":"2012","unstructured":"Griffin JE, et al. Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations. Chem Biol. 2012;19(2):218\u201327.","journal-title":"Chem Biol"},{"issue":"1","key":"609_CR73","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s12887-019-1782-2","volume":"19","author":"W Li","year":"2019","unstructured":"Li W, et al. Characterization of gut microbiota in children with pulmonary tuberculosis. BMC Pediatr. 2019;19(1):445.","journal-title":"BMC Pediatr"},{"issue":"4","key":"609_CR74","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jinf.2018.08.006","volume":"78","author":"Y Hu","year":"2019","unstructured":"Hu Y, et al. Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs. J Infect. 2019;78(4):317\u201322.","journal-title":"J Infect"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-024-00609-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-024-00609-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-024-00609-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T05:27:13Z","timestamp":1731562033000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-024-00609-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["609"],"URL":"https:\/\/doi.org\/10.1186\/s13099-024-00609-9","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"assertion":[{"value":"11 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For every participant in the study, informed consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}